BB Biotech AG
Stock Forecast, Prediction & Price Target

	Passed			Analyst forecast
Metric	12/31/2021	12/31/2022	12/31/2023	12/31/2025	12/31/2026
Revenue % change YoY	CHF-396.22M N/A	CHF-351.22M 11.35%	CHF-199.56M 43.18%	Avg: CHF134.25M Low: CHF134.25M High: CHF134.25M avg. 167.27%	Avg: CHF306.1M Low: CHF306.1M High: CHF306.1M avg. 128.00%
Net Income % change YoY	CHF-404.80M N/A	CHF-357.81M 11.60%	CHF-206.60M 42.25%	Avg: CHF95.33M Low: CHF231.99M High: CHF231.99M avg. 146.14%	Avg: CHF269.6M Low: CHF269.84M High: CHF269.84M avg. 182.79%
EBITDA % change YoY	CHF-404.74M N/A	CHF-356.02M 12.03%	CHF-201.25M 43.47%	Avg: CHF133.64M Low: CHF133.64M High: CHF133.64M avg. 166.40%	Avg: CHF304.70M Low: CHF304.70M High: CHF304.70M avg. 128.00%
EPS % change YoY	-$7.31 N/A	-$6.5 11.08%	-$3.77 42%	Avg: $4.23 Low: $4.23 High: $4.23 avg. 212.20%	Avg: $4.92 Low: $4.92 High: $4.92 avg. 16.31%
Operating Expenses % change YoY	CHF8.52M N/A	CHF6.52M -23.43%	CHF-199.56M -3158.96%	Avg: CHF-1.19M Low: CHF-1.19M High: CHF-1.19M avg. 99.40%	Avg: CHF-2.71M Low: CHF-2.71M High: CHF-2.71M avg. -128.00%

FAQ

Wall Street analysts estimate the annual average earnings growth rate of 164.46% in 2025-2026.

We have gathered data from 2 analysts. Their low estimate is 231.99M, average is 95.33M and high is 231.99M.

Wall Street analysts forecast annual average revenue growth of 147.63% in 2025-2026.

We have gathered data from 2 analysts. Their low revenue estimate is CHF134.25M, average is CHF134.25M and high is CHF134.25M.

Wall Street analysts forecast annual average earnings growth of 114.25% in 2025-2026.

We have gathered data from 2 analysts. Their low earnings per share estimate is $4.23, average is $4.23 and high is CHF4.23.